Figure 4
From: Effect of CCL5 expression in the recruitment of immune cells in triple negative breast cancer
Meta-analysis of CCL5 in recurrence-free survival (RFS) in TNBC (using the median of expression as cutoff) in databases of KM plotter. A High expression of CCL5 was associated with good prognosis (P = 0.0012).
